Potential HIV cure Phase I trial gets FDA green light
American Gene Technologies has received the agency’s approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
American Gene Technologies has received the agency’s approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
The medical organization has selected Rx.Health's TrialEngage, a set of digital tools geared toward supporting and improving decentralized trials.
When growing market demand moved the Michigan CDMO to expand, it opted for a novel design-construction approach to building bigger digs.